Blue gradient background with vertical rounded lines in varying shades of blue scattered across the right side.Blue gradient background with vertical rounded lines in varying shades of blue scattered across the right side.
On-demand education
Filter
FILTER BY TESTS
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

GNAQ and GNA11 mutations in uveal melanoma. Melanoma Res 2014;24:525-34.

December 1, 2014
DecisionDx-UM
Authors: Shoushtari AN and Carvajal RD.
Prognostic
Ophthalmology

Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma. Invest Ophthalmol Vis Sci 2014;55:5160-7.

August 1, 2014
DecisionDx-UM
Authors: Ewens KG, Kanetsky PA, Richards-Yutz J, et al.
Prognostic
Ophthalmology

Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.

July 9, 2014
DecisionDx-UM
Authors: Aaberg TM, Cook RW, Oelschlager KM, et al.
Prognostic
Ophthalmology

Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin in Ophthalmol 2014;25(3):234-9.

May 25, 2014
DecisionDx-UM
Authors: Field MG & Harbour JW.
Prognostic
Ophthalmology

SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov 2013;3:1122-9.

October 10, 2013
DecisionDx-UM
Authors: Furney SJ, Pedersen M, Gentien D, et al.
Prognostic
Ophthalmology

Collaborative Ocular Oncology Group Report Number 1: Prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology 2012;119: 1596-1603.

August 1, 2013
DecisionDx-UM
Authors: Onken MD, Worley LA, Char CH, et al
Prognostic
Ophthalmology

Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet 2013;45:933-6.

June 23, 2013
DecisionDx-UM
Authors: Martin M, Masshofer L, Temming P, et al.
Prognostic
Ophthalmology

Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications. Graefes Arch Clin Exp Ophthalmol 2014;252(1):131-5.

June 13, 2013
DecisionDx-UM
Authors: Correa ZM & Augsburger JJ.
Prognostic
Ophthalmology

The DecisionDx-UM gene expression profile test provides risk stratification and individualized patient care in uveal melanoma. PLoS Curr 2013. doi: 10.1371/currents.eogt.af8ba80fc776c8f1ce8f5dc485d4a618.

April 9, 2013
DecisionDx-UM
Authors: Harbour JW & Chen R.
Prognostic
Ophthalmology

Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases. Pigment Cell Melanoma Res 2013;26:278-9.

March 26, 2013
DecisionDx-UM
Authors: Aoude LG, Vajdic CM, Kricker A, et al.
Prognostic
Ophthalmology

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet 2013;45:133-5.

January 13, 2013
DecisionDx-UM
Authors: Harbour JW, Roberson ED, Anbunathan H, et al.
Prognostic
Ophthalmology

Uveal melanoma prognostication: from lesion size and cell type to molecular class. Can J Ophthalmol 2012;47:246-253.

June 1, 2012
DecisionDx-UM
Authors: Gill HS & Char DH.
Prognostic
Ophthalmology